154 related articles for article (PubMed ID: 20827191)
1. Modified phospholipids as anti-inflammatory compounds.
Feige E; Mendel I; George J; Yacov N; Harats D
Curr Opin Lipidol; 2010 Dec; 21(6):525-9. PubMed ID: 20827191
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.
Feige E; Yacov N; Salem Y; Levi I; Mendel I; Propheta-Meiran O; Shoham A; Hait-Darshan R; Polonsky O; George J; Harats D; Breitbart E
Atherosclerosis; 2013 Aug; 229(2):430-9. PubMed ID: 23880199
[TBL] [Abstract][Full Text] [Related]
3. The role of oxidized phospholipids in the development of disease.
Nie J; Yang J; Wei Y; Wei X
Mol Aspects Med; 2020 Dec; 76():100909. PubMed ID: 33023753
[TBL] [Abstract][Full Text] [Related]
4. Oxidized phospholipids in control of inflammation and endothelial barrier.
Fu P; Birukov KG
Transl Res; 2009 Apr; 153(4):166-76. PubMed ID: 19304275
[TBL] [Abstract][Full Text] [Related]
5. Hormetic and anti-inflammatory properties of oxidized phospholipids.
Mauerhofer C; Philippova M; Oskolkova OV; Bochkov VN
Mol Aspects Med; 2016 Jun; 49():78-90. PubMed ID: 26948981
[TBL] [Abstract][Full Text] [Related]
6. Oxidised phospholipid regulation of Toll-like receptor signalling.
Erridge C; Spickett CM
Redox Rep; 2007; 12(1):76-80. PubMed ID: 17263915
[TBL] [Abstract][Full Text] [Related]
7. The regulation of inflammation by oxidized phospholipids.
Freigang S
Eur J Immunol; 2016 Aug; 46(8):1818-25. PubMed ID: 27312261
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapeutic strategies for chronic inflammatory diseases.
Ferrer E
Drug News Perspect; 2006; 19(6):353-8. PubMed ID: 16971972
[TBL] [Abstract][Full Text] [Related]
9. [Oxidized phospholipids and atherosclerosis].
Zhao M; Liu BY; Qin SC
Sheng Li Xue Bao; 2021 Feb; 73(1):69-81. PubMed ID: 33665662
[TBL] [Abstract][Full Text] [Related]
10. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
11. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation.
Oskolkova OV; Afonyushkin T; Preinerstorfer B; Bicker W; von Schlieffen E; Hainzl E; Demyanets S; Schabbauer G; Lindner W; Tselepis AD; Wojta J; Binder BR; Bochkov VN
J Immunol; 2010 Dec; 185(12):7706-12. PubMed ID: 21068406
[TBL] [Abstract][Full Text] [Related]
12. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.
Clanchy FI; Sacre SM
Expert Opin Biol Ther; 2010 Dec; 10(12):1703-16. PubMed ID: 21039312
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
Achek A; Yesudhas D; Choi S
Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
[TBL] [Abstract][Full Text] [Related]
14. Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
Lai CY; Su YW; Lin KI; Hsu LC; Chuang TH
J Immunol Res; 2017; 2017():7807313. PubMed ID: 28894754
[TBL] [Abstract][Full Text] [Related]
15. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids.
von Schlieffen E; Oskolkova OV; Schabbauer G; Gruber F; Blüml S; Genest M; Kadl A; Marsik C; Knapp S; Chow J; Leitinger N; Binder BR; Bochkov VN
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):356-62. PubMed ID: 19112167
[TBL] [Abstract][Full Text] [Related]
16. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40.
Blüml S; Kirchberger S; Bochkov VN; Krönke G; Stuhlmeier K; Majdic O; Zlabinger GJ; Knapp W; Binder BR; Stöckl J; Leitinger N
J Immunol; 2005 Jul; 175(1):501-8. PubMed ID: 15972685
[TBL] [Abstract][Full Text] [Related]
17. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.
Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM
J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559
[TBL] [Abstract][Full Text] [Related]
18. Oxidized phospholipids as triggers of inflammation in atherosclerosis.
Leitinger N
Mol Nutr Food Res; 2005 Nov; 49(11):1063-71. PubMed ID: 16270279
[TBL] [Abstract][Full Text] [Related]
19. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of oxidized phospholipids.
Bochkov V; Gesslbauer B; Mauerhofer C; Philippova M; Erne P; Oskolkova OV
Free Radic Biol Med; 2017 Oct; 111():6-24. PubMed ID: 28027924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
